7481 - 7490 of 7916 Results
Title
Year
- Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal Model2011OPENTitle: Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal ModelJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 21Start Page: 7639End Page: 7647Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm200956qBest OA location URL: https://europepmc.org/articles/pmc3226828?pdf=renderCitation Count: 58
-
RESTRICTEDTitle: α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's DiseaseJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 63Issue #: 4Start Page: 938End Page: 966Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/pr.110.003269Best OA location URL: https://europepmc.org/articles/pmc3186078?pdf=renderCitation Count: 171
-
RESTRICTEDTitle: Cell Therapeutics in Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 8Issue #: 4Start Page: 539End Page: 548Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1007/s13311-011-0069-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-011-0069-6.pdfCitation Count: 78
-
OPENTitle: Plasticity in Early Alzheimer DiseaseJournal Name: Topics in Geriatric RehabilitationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 27Issue #: 4Start Page: 257End Page: 267Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/tgr.0b013e31821e588eBest OA location URL: https://europepmc.org/articles/pmc3419487?pdf=renderCitation Count: 36
-
RESTRICTEDTitle: Regulation of myocyte enhancer factor-2 transcription factors by neurotoxinsJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 32Issue #: 5Start Page: 563End Page: 566Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2011.05.019Best OA location URL: https://europepmc.org/articles/pmc3200477?pdf=renderCitation Count: 15
- Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders2011RESTRICTEDTitle: Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disordersJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 82Issue #: 8Start Page: 873End Page: 882Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2011.06.001Best OA location URL: https://europepmc.org/articles/pmc3264546?pdf=renderCitation Count: 78
-
OPENTitle: β-Hexachlorocyclohexane levels in serum and risk of Parkinson's diseaseJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 32Issue #: 5Start Page: 640End Page: 645Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2011.04.002Best OA location URL: https://doi.org/10.1016/j.neuro.2011.04.002Citation Count: 53
-
OPENTitle: Apathy and Depression: Separate Factors in Parkinson's DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 17Issue #: 6Start Page: 1058End Page: 1066Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617711001068Best OA location URL: https://europepmc.org/articles/pmc3302577?pdf=renderCitation Count: 125
-
OPENTitle: GFAP mutations, age at onset, and clinical subtypes in Alexander diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 13Start Page: 1287End Page: 1294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182309f72Best OA location URL: https://europepmc.org/articles/pmc3179649?pdf=renderCitation Count: 207
-
OPENTitle: Subthalamic nucleus stimulation reverses mediofrontal influence over decision thresholdJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 14Issue #: 11Start Page: 1462End Page: 1467Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.2925Best OA location URL: https://europepmc.org/articles/pmc3394226?pdf=renderCitation Count: 608